Acurx Pharmaceuticals Announces $1.1 Million Direct Offering for New Antibiotics Development Acurx Pharmaceuticals has unveiled a $1.1 million registered direct offering to support the development of its groundbreaking antibiotics, aimed at combating challenging bacterial infections.

Acurx Pharmaceuticals Announces $1.1 Million Direct Offering for New Antibiotics Development #United_States #stock_offering #Staten_Island #Acurx_Pharmaceuticals #Antibiotics_Development